|4Sep 5, 4:31 PM ET

Chapman Gina 4

4 · Entrada Therapeutics, Inc. · Filed Sep 5, 2023

Insider Transaction Report

Form 4
Period: 2023-09-01
Chapman Gina
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-09-01+32,00032,000 total
    Exercise: $15.41Exp: 2033-09-01Common Stock (32,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest in equal monthly installments over three years from the date of grant, subject to the reporting person's continuous service through the applicable vesting date.

Documents

1 file
  • 4
    wf-form4_169394589181133.xmlPrimary

    FORM 4